HEADER RECEPTOR 20-OCT-11 4A4W TITLE LIGAND BINDING DOMAIN OF HUMAN PPAR GAMMA IN COMPLEX WITH AMORFRUTIN B COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 195-477; COMPND 5 SYNONYM: PPAR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET28A KEYWDS RECEPTOR, AGONIST, DIABETES, INSULIN RESISTANCE EXPDTA X-RAY DIFFRACTION AUTHOR J.C.DE GROOT,C.WEIDNER,J.KRAUSZE,K.KAWAMOTO,F.C.SCHROEDER,S.SAUER, AUTHOR 2 K.BUESSOW REVDAT 3 20-DEC-23 4A4W 1 REMARK REVDAT 2 05-FEB-14 4A4W 1 JRNL REVDAT 1 03-OCT-12 4A4W 0 JRNL AUTH J.C.DE GROOT,C.WEIDNER,J.KRAUSZE,K.KAWAMOTO,F.C.SCHROEDER, JRNL AUTH 2 S.SAUER,K.BUSSOW JRNL TITL STRUCTURAL CHARACTERIZATION OF AMORFRUTINS BOUND TO THE JRNL TITL 2 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA. JRNL REF J.MED.CHEM. V. 56 1535 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23286787 JRNL DOI 10.1021/JM3013272 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 40687 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2142 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2932 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2710 REMARK 3 BIN FREE R VALUE SET COUNT : 154 REMARK 3 BIN FREE R VALUE : 0.3060 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4220 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 271 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.03000 REMARK 3 B22 (A**2) : 1.53000 REMARK 3 B33 (A**2) : -1.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.02000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.190 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.162 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.128 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.197 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4495 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6082 ; 1.186 ; 2.003 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 562 ; 5.170 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 200 ;39.504 ;25.600 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 883 ;14.419 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;16.322 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 693 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3309 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2696 ; 0.763 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4391 ; 1.403 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1799 ; 1.814 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1671 ; 3.100 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 10 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 203 A 253 REMARK 3 ORIGIN FOR THE GROUP (A): -3.9894 9.1770 -9.0061 REMARK 3 T TENSOR REMARK 3 T11: 0.2661 T22: 0.2141 REMARK 3 T33: 0.2191 T12: -0.0212 REMARK 3 T13: -0.0079 T23: -0.0010 REMARK 3 L TENSOR REMARK 3 L11: 1.6403 L22: 0.3655 REMARK 3 L33: 2.1482 L12: -0.7573 REMARK 3 L13: -0.6701 L23: 0.4261 REMARK 3 S TENSOR REMARK 3 S11: -0.1787 S12: -0.1227 S13: -0.0428 REMARK 3 S21: 0.1143 S22: 0.0975 S23: -0.0015 REMARK 3 S31: 0.0289 S32: 0.1763 S33: 0.0812 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 254 A 291 REMARK 3 ORIGIN FOR THE GROUP (A): -18.6929 27.5727 -8.8156 REMARK 3 T TENSOR REMARK 3 T11: 0.7137 T22: 0.0900 REMARK 3 T33: 0.2645 T12: 0.0205 REMARK 3 T13: -0.1628 T23: 0.0499 REMARK 3 L TENSOR REMARK 3 L11: 5.4043 L22: 1.0290 REMARK 3 L33: 7.7282 L12: -1.0318 REMARK 3 L13: -6.1527 L23: 1.8941 REMARK 3 S TENSOR REMARK 3 S11: 0.4158 S12: -0.0700 S13: 0.6569 REMARK 3 S21: 0.0888 S22: 0.2083 S23: -0.0197 REMARK 3 S31: -0.6501 S32: 0.3241 S33: -0.6241 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 292 A 428 REMARK 3 ORIGIN FOR THE GROUP (A): -11.8254 8.9790 -19.0895 REMARK 3 T TENSOR REMARK 3 T11: 0.1974 T22: 0.2102 REMARK 3 T33: 0.2205 T12: -0.0376 REMARK 3 T13: -0.0066 T23: 0.0025 REMARK 3 L TENSOR REMARK 3 L11: 0.6230 L22: 0.5299 REMARK 3 L33: 1.1612 L12: -0.2319 REMARK 3 L13: -0.3232 L23: 0.1275 REMARK 3 S TENSOR REMARK 3 S11: -0.0408 S12: 0.0418 S13: -0.0591 REMARK 3 S21: 0.0421 S22: 0.0461 S23: 0.0816 REMARK 3 S31: -0.0536 S32: -0.0992 S33: -0.0053 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 429 A 460 REMARK 3 ORIGIN FOR THE GROUP (A): -22.1997 8.6742 -20.9761 REMARK 3 T TENSOR REMARK 3 T11: 0.1738 T22: 0.2617 REMARK 3 T33: 0.2745 T12: -0.0806 REMARK 3 T13: -0.0082 T23: 0.0047 REMARK 3 L TENSOR REMARK 3 L11: 2.4255 L22: 7.2722 REMARK 3 L33: 0.3433 L12: -4.0957 REMARK 3 L13: 0.5493 L23: -0.9733 REMARK 3 S TENSOR REMARK 3 S11: 0.0448 S12: 0.1593 S13: -0.1314 REMARK 3 S21: -0.0085 S22: -0.0582 S23: 0.2621 REMARK 3 S31: 0.0460 S32: -0.1135 S33: 0.0134 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 461 A 477 REMARK 3 ORIGIN FOR THE GROUP (A): -20.3235 24.1629 -26.1783 REMARK 3 T TENSOR REMARK 3 T11: 0.3683 T22: 0.2044 REMARK 3 T33: 0.2752 T12: -0.0025 REMARK 3 T13: -0.0195 T23: 0.0515 REMARK 3 L TENSOR REMARK 3 L11: 5.7787 L22: 9.5299 REMARK 3 L33: 0.0472 L12: -7.4199 REMARK 3 L13: -0.5054 L23: 0.6503 REMARK 3 S TENSOR REMARK 3 S11: 0.2935 S12: 0.2437 S13: -0.4500 REMARK 3 S21: -0.4039 S22: -0.3228 S23: 0.6014 REMARK 3 S31: -0.0587 S32: -0.0223 S33: 0.0293 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 206 B 239 REMARK 3 ORIGIN FOR THE GROUP (A): -22.1948 -22.2047 -33.4175 REMARK 3 T TENSOR REMARK 3 T11: 0.2368 T22: 0.1677 REMARK 3 T33: 0.2471 T12: -0.0482 REMARK 3 T13: 0.0038 T23: -0.0430 REMARK 3 L TENSOR REMARK 3 L11: 1.2206 L22: 1.9511 REMARK 3 L33: 2.8879 L12: -0.3092 REMARK 3 L13: -0.0407 L23: -0.8916 REMARK 3 S TENSOR REMARK 3 S11: 0.0289 S12: 0.2802 S13: -0.1108 REMARK 3 S21: 0.0020 S22: -0.0012 S23: -0.0679 REMARK 3 S31: 0.3808 S32: 0.1371 S33: -0.0276 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 240 B 270 REMARK 3 ORIGIN FOR THE GROUP (A): -41.0925 -11.6996 -51.6331 REMARK 3 T TENSOR REMARK 3 T11: 0.2183 T22: 0.5084 REMARK 3 T33: 0.2917 T12: -0.0537 REMARK 3 T13: -0.2038 T23: -0.0889 REMARK 3 L TENSOR REMARK 3 L11: 2.4373 L22: 0.8071 REMARK 3 L33: 7.9840 L12: -0.3562 REMARK 3 L13: -2.1978 L23: -1.3914 REMARK 3 S TENSOR REMARK 3 S11: 0.3191 S12: 0.8273 S13: -0.5706 REMARK 3 S21: -0.0743 S22: -0.3205 S23: 0.0617 REMARK 3 S31: 0.3257 S32: -0.7642 S33: 0.0014 REMARK 3 REMARK 3 TLS GROUP : 8 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 275 B 428 REMARK 3 ORIGIN FOR THE GROUP (A): -28.8650 -9.8466 -31.4895 REMARK 3 T TENSOR REMARK 3 T11: 0.2031 T22: 0.2080 REMARK 3 T33: 0.2181 T12: -0.0462 REMARK 3 T13: 0.0111 T23: -0.0008 REMARK 3 L TENSOR REMARK 3 L11: 0.7249 L22: 0.3444 REMARK 3 L33: 0.9806 L12: 0.0454 REMARK 3 L13: -0.0120 L23: -0.0656 REMARK 3 S TENSOR REMARK 3 S11: 0.0287 S12: 0.0910 S13: 0.0438 REMARK 3 S21: -0.0180 S22: -0.0101 S23: -0.0073 REMARK 3 S31: -0.0511 S32: -0.0602 S33: -0.0187 REMARK 3 REMARK 3 TLS GROUP : 9 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 429 B 456 REMARK 3 ORIGIN FOR THE GROUP (A): -25.3777 -0.8042 -29.7972 REMARK 3 T TENSOR REMARK 3 T11: 0.2494 T22: 0.2261 REMARK 3 T33: 0.2603 T12: -0.0166 REMARK 3 T13: 0.0534 T23: 0.0564 REMARK 3 L TENSOR REMARK 3 L11: 10.7101 L22: 2.9790 REMARK 3 L33: 0.4314 L12: -4.4204 REMARK 3 L13: 0.5368 L23: 0.4600 REMARK 3 S TENSOR REMARK 3 S11: 0.0958 S12: 0.1025 S13: 0.5153 REMARK 3 S21: -0.2245 S22: -0.1214 S23: -0.2119 REMARK 3 S31: -0.1248 S32: -0.0311 S33: 0.0256 REMARK 3 REMARK 3 TLS GROUP : 10 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 457 B 474 REMARK 3 ORIGIN FOR THE GROUP (A): -51.1276 -1.9024 -32.1015 REMARK 3 T TENSOR REMARK 3 T11: 0.4538 T22: 0.2128 REMARK 3 T33: 0.4888 T12: -0.1244 REMARK 3 T13: 0.2001 T23: 0.2125 REMARK 3 L TENSOR REMARK 3 L11: 0.6275 L22: 18.5579 REMARK 3 L33: 0.4833 L12: 3.3512 REMARK 3 L13: -0.5470 L23: -2.9832 REMARK 3 S TENSOR REMARK 3 S11: -0.0134 S12: 0.1022 S13: 0.1687 REMARK 3 S21: 0.1994 S22: 0.1768 S23: 0.3961 REMARK 3 S31: -0.0520 S32: -0.0544 S33: -0.1634 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4A4W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-OCT-11. REMARK 100 THE DEPOSITION ID IS D_1290049949. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-SEP-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5419 REMARK 200 MONOCHROMATOR : RIGAKU VARIMAX REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU-MSC SATURN 944 PLUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42829 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 29.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.45000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1PRG REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8 M TRI-SODIUM CITRATE 0.1 M REMARK 280 IMIDAZOLE, PH 8.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.07000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.43000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.07000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.43000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 191 REMARK 465 SER A 192 REMARK 465 HIS A 193 REMARK 465 MET A 194 REMARK 465 ALA A 195 REMARK 465 GLU A 196 REMARK 465 ILE A 197 REMARK 465 SER A 198 REMARK 465 SER A 199 REMARK 465 ASP A 200 REMARK 465 ILE A 201 REMARK 465 ASP A 202 REMARK 465 ILE A 262 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 GLY B 191 REMARK 465 SER B 192 REMARK 465 HIS B 193 REMARK 465 MET B 194 REMARK 465 ALA B 195 REMARK 465 GLU B 196 REMARK 465 ILE B 197 REMARK 465 SER B 198 REMARK 465 SER B 199 REMARK 465 ASP B 200 REMARK 465 ILE B 201 REMARK 465 ASP B 202 REMARK 465 GLN B 203 REMARK 465 LEU B 204 REMARK 465 ASN B 205 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 ASP B 475 REMARK 465 LEU B 476 REMARK 465 TYR B 477 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 240 44.06 -71.39 REMARK 500 GLU A 460 69.14 -116.30 REMARK 500 LYS A 474 108.48 -55.41 REMARK 500 LYS B 244 80.97 52.89 REMARK 500 SER B 464 57.56 -157.14 REMARK 500 HIS B 466 121.40 -30.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS A 240 THR A 241 -141.14 REMARK 500 THR A 241 THR A 242 141.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2049 DISTANCE = 5.90 ANGSTROMS REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YFB A 999 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YFB B 999 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FVJ RELATED DB: PDB REMARK 900 A NOVEL ANTI-ADIPOGENIC PARTIAL AGONIST OF PEROXISOMEPROLIFERATOR- REMARK 900 ACTIVATED RECEPTOR-GAMMA (PPARG) RECRUITSPPARG-COACTIVATOR-1 ALPHA REMARK 900 (PGC1A) BUT POTENTIATES INSULINSIGNALING IN VITRO REMARK 900 RELATED ID: 2XKW RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE REMARK 900 AGONIST PIOGLITAZONE REMARK 900 RELATED ID: 2VV2 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 5- HEPA REMARK 900 RELATED ID: 1FM9 RELATED DB: PDB REMARK 900 THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THEHETERODIMER OF REMARK 900 THE HUMAN RXRALPHA AND PPARGAMMA LIGANDBINDING DOMAINS RESPECTIVELY REMARK 900 BOUND WITH 9-CIS RETINOIC ACIDAND GI262570 AND CO-ACTIVATOR REMARK 900 PEPTIDES. REMARK 900 RELATED ID: 2VV0 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH DHA REMARK 900 RELATED ID: 2VV1 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 4- HDHA REMARK 900 RELATED ID: 2PRG RELATED DB: PDB REMARK 900 LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR REMARK 900 ACTIVATED RECEPTOR GAMMA REMARK 900 RELATED ID: 1KNU RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATORACTIVATED REMARK 900 RECEPTOR GAMMA IN COMPLEX WITH A SYNTHETICAGONIST REMARK 900 RELATED ID: 1RDT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A NEW REXINOID BOUND TO THE RXRALPHALIGAND REMARK 900 BINDING DOAMIN IN THE RXRALPHA/PPARGAMMA HETERODIMER REMARK 900 RELATED ID: 2VV4 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 6- OXOOTE REMARK 900 RELATED ID: 3PRG RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED REMARK 900 RECEPTOR REMARK 900 RELATED ID: 1I7I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMANPPAR-GAMMA REMARK 900 IN COMPLEX WITH THE AGONIST AZ 242 REMARK 900 RELATED ID: 1K74 RELATED DB: PDB REMARK 900 THE 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THEHETERODIMER OF REMARK 900 THE HUMAN PPARGAMMA AND RXRALPHA LIGANDBINDING DOMAINS RESPECTIVELY REMARK 900 BOUND WITH GW409544 AND 9-CISRETINOIC ACID AND CO-ACTIVATOR REMARK 900 PEPTIDES. REMARK 900 RELATED ID: 1FM6 RELATED DB: PDB REMARK 900 THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THEHETERODIMER OF REMARK 900 THE HUMAN RXRALPHA AND PPARGAMMA LIGANDBINDING DOMAINS RESPECTIVELY REMARK 900 BOUND WITH 9-CIS RETINOIC ACIDAND ROSIGLITAZONE AND CO-ACTIVATOR REMARK 900 PEPTIDES. REMARK 900 RELATED ID: 1PRG RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR REMARK 900 ACTIVATED RECEPTOR GAMMA REMARK 900 RELATED ID: 1ZGY RELATED DB: PDB REMARK 900 STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSIONOF THE REMARK 900 ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP REMARK 900 RELATED ID: 2F4B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMANPPAR-GAMMA REMARK 900 IN COMPLEX WITH AN AGONIST REMARK 900 RELATED ID: 2VST RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 13-(S )-HODE REMARK 900 RELATED ID: 2G0H RELATED DB: PDB REMARK 900 STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPARPARTIAL REMARK 900 AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHYAND IN VITRO/IN REMARK 900 VIVO BIOLOGICAL ACTIVITIES REMARK 900 RELATED ID: 2VSR RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 9-(S )-HODE REMARK 900 RELATED ID: 1WM0 RELATED DB: PDB REMARK 900 PPARGAMMA IN COMPLEX WITH A 2-BABA COMPOUND REMARK 900 RELATED ID: 4PRG RELATED DB: PDB REMARK 900 0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL REMARK 900 RELATED ID: 2G0G RELATED DB: PDB REMARK 900 STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPARPARTIAL REMARK 900 AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHYAND IN VITRO/IN REMARK 900 VIVO BIOLOGICAL ACTIVITIES REMARK 900 RELATED ID: 1NYX RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATORACTIVATED REMARK 900 RECEPTOR GAMMA IN COMPLEX WITH AN AGONIST REMARK 900 RELATED ID: 2VV3 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 4- OXODHA REMARK 900 RELATED ID: 2YFE RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF HUMAN PPAR GAMMA IN COMPLEX WITH REMARK 900 AMORFRUTIN 1 REMARK 900 RELATED ID: 4A4V RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF HUMAN PPAR GAMMA IN COMPLEX WITH REMARK 900 AMORFRUTIN 2 DBREF 4A4W A 195 477 UNP P37231 PPARG_HUMAN 195 477 DBREF 4A4W B 195 477 UNP P37231 PPARG_HUMAN 195 477 SEQADV 4A4W GLY A 191 UNP P37231 EXPRESSION TAG SEQADV 4A4W SER A 192 UNP P37231 EXPRESSION TAG SEQADV 4A4W HIS A 193 UNP P37231 EXPRESSION TAG SEQADV 4A4W MET A 194 UNP P37231 EXPRESSION TAG SEQADV 4A4W GLY B 191 UNP P37231 EXPRESSION TAG SEQADV 4A4W SER B 192 UNP P37231 EXPRESSION TAG SEQADV 4A4W HIS B 193 UNP P37231 EXPRESSION TAG SEQADV 4A4W MET B 194 UNP P37231 EXPRESSION TAG SEQRES 1 A 287 GLY SER HIS MET ALA GLU ILE SER SER ASP ILE ASP GLN SEQRES 2 A 287 LEU ASN PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS SEQRES 3 A 287 HIS LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR SEQRES 4 A 287 LYS ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR SEQRES 5 A 287 ASP LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU SEQRES 6 A 287 MET MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR SEQRES 7 A 287 PRO LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE SEQRES 8 A 287 PHE GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN SEQRES 9 A 287 GLU ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL SEQRES 10 A 287 ASN LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR SEQRES 11 A 287 GLY VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU SEQRES 12 A 287 MET ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY SEQRES 13 A 287 PHE MET THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO SEQRES 14 A 287 PHE GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL SEQRES 15 A 287 LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA SEQRES 16 A 287 ILE PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO SEQRES 17 A 287 GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP SEQRES 18 A 287 ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN SEQRES 19 A 287 HIS PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN SEQRES 20 A 287 LYS MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL SEQRES 21 A 287 GLN LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SEQRES 22 A 287 SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU SEQRES 23 A 287 TYR SEQRES 1 B 287 GLY SER HIS MET ALA GLU ILE SER SER ASP ILE ASP GLN SEQRES 2 B 287 LEU ASN PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS SEQRES 3 B 287 HIS LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR SEQRES 4 B 287 LYS ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR SEQRES 5 B 287 ASP LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU SEQRES 6 B 287 MET MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR SEQRES 7 B 287 PRO LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE SEQRES 8 B 287 PHE GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN SEQRES 9 B 287 GLU ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL SEQRES 10 B 287 ASN LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR SEQRES 11 B 287 GLY VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU SEQRES 12 B 287 MET ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY SEQRES 13 B 287 PHE MET THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO SEQRES 14 B 287 PHE GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL SEQRES 15 B 287 LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA SEQRES 16 B 287 ILE PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO SEQRES 17 B 287 GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP SEQRES 18 B 287 ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN SEQRES 19 B 287 HIS PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN SEQRES 20 B 287 LYS MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL SEQRES 21 B 287 GLN LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SEQRES 22 B 287 SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU SEQRES 23 B 287 TYR HET YFB A 999 30 HET YFB B 999 30 HETNAM YFB AMORFRUTIN B FORMUL 3 YFB 2(C26 H32 O4) FORMUL 5 HOH *271(H2 O) HELIX 1 1 PRO A 206 SER A 225 1 20 HELIX 2 2 LYS A 230 THR A 238 1 9 HELIX 3 3 MET A 252 GLY A 258 1 7 HELIX 4 4 VAL A 277 SER A 302 1 26 HELIX 5 5 LEU A 311 SER A 332 1 22 HELIX 6 6 ARG A 350 LYS A 354 1 5 HELIX 7 7 GLU A 365 ASN A 375 1 11 HELIX 8 8 ASP A 381 ILE A 392 1 12 HELIX 9 9 VAL A 403 ASN A 424 1 22 HELIX 10 10 LEU A 431 THR A 459 1 29 HELIX 11 11 PRO A 467 TYR A 473 1 7 HELIX 12 12 SER B 208 SER B 225 1 18 HELIX 13 13 LYS B 230 THR B 238 1 9 HELIX 14 14 MET B 252 LYS B 261 1 10 HELIX 15 15 VAL B 277 LYS B 301 1 25 HELIX 16 16 LEU B 311 ALA B 331 1 21 HELIX 17 17 ARG B 350 SER B 355 1 6 HELIX 18 18 GLU B 365 ASN B 375 1 11 HELIX 19 19 ASP B 381 ILE B 392 1 12 HELIX 20 20 VAL B 403 ASN B 424 1 22 HELIX 21 21 LEU B 431 THR B 459 1 29 HELIX 22 22 PRO B 467 ILE B 472 1 6 SHEET 1 1 1 PHE A 247 ILE A 249 0 SHEET 1 2 1 MET A 334 ASN A 335 0 SHEET 1 3 1 GLY A 338 ILE A 341 0 SHEET 1 4 1 GLY A 346 THR A 349 0 SHEET 1 5 1 PHE B 247 ILE B 249 0 SHEET 1 6 1 MET B 334 ASN B 335 0 SHEET 1 7 1 GLY B 338 ILE B 341 0 SHEET 1 8 1 GLY B 346 THR B 349 0 CISPEP 1 LYS A 358 PRO A 359 0 -0.98 CISPEP 2 LYS B 358 PRO B 359 0 0.42 SITE 1 AC1 12 GLU A 259 ILE A 281 CYS A 285 ARG A 288 SITE 2 AC1 12 ILE A 326 MET A 329 LEU A 330 ILE A 341 SITE 3 AC1 12 SER A 342 MET A 348 LEU A 353 HOH A2042 SITE 1 AC2 12 PHE B 226 GLY B 284 CYS B 285 ARG B 288 SITE 2 AC2 12 SER B 289 ALA B 292 MET B 329 LEU B 330 SITE 3 AC2 12 LEU B 333 LEU B 340 SER B 342 HOH B2037 CRYST1 92.140 60.860 117.600 90.00 102.58 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010853 0.000000 0.002422 0.00000 SCALE2 0.000000 0.016431 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008713 0.00000 MTRIX1 1 0.099060 -0.977110 0.188260 -13.86474 1 MTRIX2 1 -0.984160 -0.124150 -0.126530 -23.26374 1 MTRIX3 1 0.147000 -0.172740 -0.973940 -46.05626 1